Erlotinib Sun

Erlotinib Sun is an oral medication used to treat certain types of cancer. This pharmaceutical is manufactured by Sun Pharmaceutical Industries Europe B.V. and is designed for oral use.

Erlotinib Sun is primarily used in the treatment of specific types of cancer. It works by targeting certain proteins involved in cancer cell growth. Patients often wonder, 'What is Erlotinib used for?' This medication is typically prescribed for advanced or metastatic non-small cell lung cancer and pancreatic cancer.

Common effects of Erlotinib Sun may include skin rash, diarrhea, and fatigue. Some users may also experience appetite loss and dry skin. These effects can vary from person to person and are not experienced by everyone who takes the medication.

Erlotinib Sun should be handled with care. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Patients should avoid breaking or crushing the tablets unless directed to do so.

Erlotinib Sun may interact with certain medications, including those that are metabolized by the liver's CYP3A4 enzyme. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, grapefruit and grapefruit juice should be avoided as they can affect the metabolism of Erlotinib.